Flavonoids

5,7-Dihydroxyisoflavone is a naturally occurring isoflavone, which is a type of flavonoid compound commonly found in various plants. It is primarily derived from sources such as soybeans and other legumes, which are known to contain a wide array of phytonutrients. The mode of action of 5,7-Dihydroxyisoflavone involves its ability to act as an antioxidant, scavenging free radicals and thereby reducing oxidative stress within biological systems. This function is crucial in preserving cellular health and preventing damage that can lead to chronic diseases. The uses and applications of 5,7-Dihydroxyisoflavone are diverse, particularly in the fields of biochemistry and pharmacology. It has been studied for its potential roles in modulating signaling pathways involved in cellular proliferation and apoptosis. Additionally, its presence in dietary sources has contributed to research on its effects on hormone-related conditions, such as menopausal symptoms, due to its ability to engage with estrogen receptors. The compound is also being explored for its potential in protective cardiovascular functions and other health-related benefits, making it a subject of interest in the development of nutraceuticals and functional foods.

7-Hydroxy-5-methoxyflavanone is a naturally occurring flavanone compound, which is derived from various plant sources. These sources often include fruits, vegetables, and certain medicinal herbs, known for their rich flavonoid content. The mode of action of 7-Hydroxy-5-methoxyflavanone primarily involves its role as an antioxidant. It helps in scavenging free radicals and reducing oxidative stress, which is a common pathway in cellular protection against damage. In terms of uses and applications, 7-Hydroxy-5-methoxyflavanone is of particular interest in the scientific community for its potential therapeutic properties. Researchers investigate its role in various biological activities including anti-inflammatory, cardioprotective, and neuroprotective effects. It is also studied for its potential application in pharmaceutical formulations aimed at improving health outcomes related to oxidative stress. The compound is a subject of interest in the development of supplements and nutraceuticals, exploring its efficacy as a bioactive ingredient that can contribute to health maintenance and disease prevention.

7,4'-Dimethoxyflavone is a naturally occurring flavonoid derivative, which is found predominantly in certain plants, particularly within the citrus family. This compound is characterized by the presence of two methoxy groups attached to its flavone backbone. It functions by interacting with various biological pathways, including those involved in antioxidant and anti-inflammatory responses. Its molecular structure allows it to modulate enzyme activities and receptor interactions, although the exact mechanisms are still under study. The primary applications of 7,4'-Dimethoxyflavone are observed in the fields of pharmacology and nutraceuticals, where it is explored for its potential therapeutic effects. Research indicates its utility in targeting oxidative stress-related disorders and as a candidate for anti-cancer research due to its ability to interfere with cell signaling pathways. Additionally, its anti-inflammatory properties are being investigated for treating chronic inflammatory conditions. Further studies are essential to fully elucidate its benefits and mechanisms of action, potentially paving the way for the development of new therapeutic agents. This compound continues to be a subject of interest due to its promising bioactivity and the potential for diverse pharmacological applications.

4'-Hydroxyflavanone analytical standard provided with chromatographic purity, to be used as reference material for qualitative determination.

Garciniflavanone is a naturally occurring flavonoid compound, which is primarily derived from plants in the Garcinia genus. It acts as an antioxidant through the scavenging of free radicals, thereby mitigating oxidative stress within cellular environments. Additionally, garciniflavanone influences various cellular signaling pathways, contributing to its anti-inflammatory and potential anticancer effects. Research studies demonstrate garciniflavanone’s promising applications in the pharmaceutical field, particularly in the development of treatments for chronic inflammation and cancer. By modulating key molecular processes, it shows potential in reducing tumor proliferation and enhancing the efficacy of traditional cancer treatments. Furthermore, its antioxidant properties are applicable in skin care formulations aimed at protecting against environmental damage and premature aging. As a bioactive compound, garciniflavanone continues to be a subject of interest for its therapeutic potential and underlines the importance of plant-derived compounds in drug discovery and development.

Erythrinin A is an alkaloid compound, which is an isolated bioactive substance derived from the Erythrina plant species. This compound is primarily sourced from the beans and bark of Erythrina plants, which are native to tropical and subtropical regions. Erythrinin A exhibits its mode of action by interacting with neurotransmitter systems within the central nervous system, possessing properties that may influence receptors such as GABA and others related to neuromodulation. The potential applications of Erythrinin A are grounded in its neuropharmacological effects. It has been the focus of research due to its potential use in treating neurological disorders, such as anxiety, depression, and epilepsy. While investigations are ongoing, the unique properties of Erythrinin A make it a promising candidate for the development of novel therapeutic agents, fostering interest in its ability to modulate synaptic transmission and exert anxiolytic or anticonvulsant effects. Studies continue to elucidate its full spectrum of activity and possible therapeutic benefits, enhancing our understanding of this intriguing alkaloid.

(S)-Equol is a non-steroidal estrogen, which is a metabolite produced by the gut microbiota from dietary isoflavones, specifically daidzein, found in soy and other legumes. It has high affinity for estrogen receptor beta, playing a significant role in modulating estrogenic activity without altering steroid hormone levels. The mode of action of (S)-Equol involves selective binding to estrogen receptors, exerting estrogen-like effects particularly in tissues like bone, brain, and cardiovascular systems, while potentially minimizing proliferative effects on breast and uterine tissues due to its preferential affinity. (S)-Equol is explored for its applications in managing menopausal symptoms, osteoporosis, and hormone-related conditions, providing an alternative to traditional hormone replacement therapies. It also holds promise as a therapeutic agent for conditions associated with estrogen deficiency. While not all individuals produce (S)-Equol naturally, due to differences in gut microbiota, understanding its biosynthesis and effects opens avenues for tailored dietary or probiotic interventions to harness its benefits.

6,3'-Diprenylgenistein is a prenylated isoflavonoid compound, which is derived from certain plants, notably those within the legume family. This phytochemical is characterized as an isoflavone, a class of naturally occurring organic compounds related to flavonoids, distinguished by the inclusion of prenyl groups that potentially enhance its biological activity and bioavailability. The mode of action of 6,3'-Diprenylgenistein involves various biochemical pathways, including interactions with estrogen receptors and modulation of enzyme activities. These interactions suggest possible roles in influencing estrogenic activity, antioxidant effects, and anti-inflammatory responses. Prenylation, as observed in this compound, often enhances cellular uptake, allowing for more effective interaction with biochemical targets compared to non-prenylated analogs. In terms of uses and applications, 6,3'-Diprenylgenistein is primarily studied for its potential therapeutic properties, with research exploring its role in cancer chemoprevention, cardiovascular health, and osteoporosis management due to its ability to mimic or inhibit estrogen effects. Additionally, this compound contributes to ongoing studies focusing on developing novel nutraceuticals and pharmaceuticals targeting various health conditions, leveraging its enhanced biological activity.

Oxygen-heterocyclic compound

Oxygen-heterocyclic compound

Wedelolactone analytical standard provided with w/w absolute assay, to be used for quantitative titration.

Quercetin-3-O-glucopyranoside analytical standard provided with w/w absolute assay, to be used for quantitative titration.

7-Methoxyflavone is a bioactive compound classified as a flavonoid, which is derived from various natural sources such as plants, fruits, and vegetables. This compound exerts its biological effects through modulation of enzyme activity and interaction with cellular signaling pathways, primarily involving the modulation of cytochrome P450 enzymes and affecting neurotransmitter systems. In the scientific context, 7-Methoxyflavone is of particular interest due to its potential neuroprotective, anti-inflammatory, and antioxidant properties. It has been investigated for its ability to influence pharmacokinetics when interacting with other substances, which could have implications for drug metabolism and efficacy. Moreover, its interaction with enzymes suggests possible applications in managing conditions like neurodegenerative diseases and certain metabolic disorders. Researchers are exploring its utility in developing new pharmacological agents, given its ability to modulate biological pathways and its relative abundance in nature. The compound's multifaceted mode of action makes it a subject of ongoing scientific studies aiming to fully elucidate its potential benefits and applications in therapeutic settings.

Isorhamnetin-5-O-methyl ether-3-glucoside is a flavonoid glycoside, which is a secondary metabolite typically found in various plant sources such as fruits, vegetables, and certain herbs. It is part of a larger class of compounds known as flavonoids, which are well-known for their diverse biological activities. The mode of action of Isorhamnetin-5-O-methyl ether-3-glucoside primarily involves its antioxidant properties, which allow it to neutralize free radicals and reduce oxidative stress. Due to its antioxidant capacity, this compound is often researched for its potential health benefits, particularly in relation to cardiovascular health, anti-inflammatory effects, and possible anticancer properties. The ability of Isorhamnetin-5-O-methyl ether-3-glucoside to modulate various signaling pathways and gene expressions also makes it a subject of interest in the field of phytotherapy and nutraceutical studies. Researchers are exploring its applications in developing food supplements and therapeutic agents aimed at preventing or ameliorating oxidative stress-related diseases. Such investigations are crucial for expanding our understanding of the full potential of this compound within biomedical and nutritional contexts.

Natural glycoside